AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33548529 — intervention group
Group type: COMPARATOR
Intervention: Control group (medical management)
Number of subjects: 21
Study 32151708 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane
Number of subjects: 26
Study 32151708 — intervention group
Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 26
Study 35585521 — intervention group
Group type: EXPERIMENTAL
Intervention: Pēpi Splint
Number of subjects: 38
Study 32385647 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 ml sodium chloride and 20 mg furosemide
Number of subjects: 200
Study 32385647 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 ml sodium chloride and 40 mg furosemide
Number of subjects: 200
Study 32385647 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 ml sodium chloride
Number of subjects: 200
Study 32385647 — intervention group
Group type: EXPERIMENTAL
Intervention: No preparation
Number of subjects: 200
Study 32385647 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preparation)
Number of subjects: 200
Study 32385647 — intervention group
Group type: COMPARATOR
Intervention: Control group (sodium chloride)
Number of subjects: 200
Study 32648395 — intervention group
Group type: EXPERIMENTAL
Intervention: herb-separated moxibustion combined with budesonide nasal spray (rhinocort), 64 μg each spray, twice daily for 4 weeks
Number of subjects: 70
Study 32648395 — intervention group
Group type: COMPARATOR
Intervention: budesonide nasal spray (rhinocort), 64 μg each spray, twice daily for 4 weeks
Number of subjects: 70
Study 35691371 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-month relational agent coupled with AliveCor Kardia for heart rate and rhythm monitoring
Number of subjects: 264
Study 35691371 — intervention group
Group type: COMPARATOR
Intervention: Pre-installed smartphone-based application for health-related information (WebMD)
Number of subjects: 264
Study 33894856 — intervention group
Group type: COMPARATOR
Intervention: Traditional Sitting Position (TSP)
Number of subjects: 360
Study 33894856 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring Stretch Position (HSP)
Number of subjects: 360
Study 33894856 — intervention group
Group type: EXPERIMENTAL
Intervention: Squatting Position (SP)
Number of subjects: 360
Study 33894856 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (TSP, HSP, SP)
Number of subjects: 360
Study 32298853 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 1155
Study 33983076 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-filled saline syringes
Number of subjects: 41
Study 33983076 — intervention group
Group type: COMPARATOR
Intervention: Manual preparation of saline syringes
Number of subjects: 41
Study 34232832 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed flexible proportional-odds models for estimating conditional event-probabilities
Number of subjects: 0
Study 32473186 — intervention group
Group type: EXPERIMENTAL
Intervention: GAMotion (giant exercising board game)
Number of subjects: 21
Study 36410828 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised postprandial glucose targeting diet
Number of subjects: 0
Study 36410828 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 0
Study 34146093 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 1272
Study 34146093 — intervention group
Group type: COMPARATOR
Intervention: Control (no BCG vaccination)
Number of subjects: 1272
Study 33658142 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention using a website to create a short film about organ donation and transplantation (broadcast on YouTube)
Number of subjects: 863
Study 33658142 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 863
Study 32249355 — intervention group
Group type: EXPERIMENTAL
Intervention: BALANCE intervention
Number of subjects: 38
Study 32249355 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 38
Study 35303929 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with propofol
Number of subjects: 400
Study 35303929 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with sevoflurane
Number of subjects: 400
Study 35303929 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with propofol and intravenous lidocaine
Number of subjects: 400
Study 35303929 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with sevoflurane and intravenous lidocaine
Number of subjects: 400
Study 33326172 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 131
Study 32610568 — intervention group
Group type: EXPERIMENTAL
Intervention: EC‐150 (intermittent external compression with pressure of 150% AOP)
Number of subjects: 10
Study 32610568 — intervention group
Group type: COMPARATOR
Intervention: CONT (control, without external compression)
Number of subjects: 10
Study 35995689 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted operating room promotion program
Number of subjects: 100
Study 35995689 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 100
Study 33308131 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological therapies
Number of subjects: 0
Study 33308131 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive therapy
Number of subjects: 0
Study 32224233 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antidiabetic drugs (glyburide, metformin, or pioglitazone)
Number of subjects: 0
Study 32224233 — intervention group
Group type: EXPERIMENTAL
Intervention: ETA-receptor blockade
Number of subjects: 0
Study 32224233 — intervention group
Group type: COMPARATOR
Intervention: Acetylcholine and sodium nitroprusside
Number of subjects: 0
Study 33865836 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 108
Study 33865836 — intervention group
Group type: COMPARATOR
Intervention: Neutral protamine Hagedorn
Number of subjects: 108
Study 34397689 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted atazanavir (ATV/r)
Number of subjects: 75
Study 34397689 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted darunavir (DRV/r)
Number of subjects: 75
Study 34397689 — intervention group
Group type: COMPARATOR
Intervention: Raltegravir (RAL)
Number of subjects: 75
Study 34397689 — intervention group
Group type: COMPARATOR
Intervention: INSTI-based regimen (RAL)
Number of subjects: 75
Study 34397689 — intervention group
Group type: COMPARATOR
Intervention: PI-based regimens (ATV/r and DRV/r)
Number of subjects: 75
Study 32789883 — intervention group
Group type: EXPERIMENTAL
Intervention: DI*02(2558T) allele
Number of subjects: 1150
Study 32789883 — intervention group
Group type: EXPERIMENTAL
Intervention: DI*02(2534T) allele
Number of subjects: 1150
Study 32789883 — intervention group
Group type: EXPERIMENTAL
Intervention: DI*02(2358_2359insCAC) allele
Number of subjects: 1150
Study 32789883 — intervention group
Group type: EXPERIMENTAL
Intervention: DI*02(2572T) allele
Number of subjects: 1150
Study 32789883 — intervention group
Group type: COMPARATOR
Intervention: Wild-type DI*02 constructs
Number of subjects: 1150
Study 35045564 — intervention group
Group type: EXPERIMENTAL
Intervention: Limosilactobacillus reuteri ATCC PTA 4659
Number of subjects: 119
Study 35045564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 34714771 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-component lifestyle intervention (LSI) with SMS support
Number of subjects: 183
Study 34714771 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-component lifestyle intervention (LSI) without SMS support
Number of subjects: 183
Study 34714771 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 183
Study 34714771 — intervention group
Group type: COMPARATOR
Intervention: Combined LSI groups vs CAU
Number of subjects: 183
Study 32464608 — intervention group
Group type: EXPERIMENTAL
Intervention: Compressed sensing convolutional neural network (CS-CNN) model for AF screening
Number of subjects: 0
Study 35549331 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 157
Study 32062040 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D3
Number of subjects: 25871
Study 32062040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25871
Study 32981134 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased levels of apoB, LDL cholesterol, and triglycerides
Number of subjects: 514791
Study 32981134 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased levels of apoA-I and HDL cholesterol
Number of subjects: 514791
Study 32981134 — intervention group
Group type: EXPERIMENTAL
Intervention: apoB
Number of subjects: 514791
Study 32981134 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL cholesterol
Number of subjects: 514791
Study 32981134 — intervention group
Group type: EXPERIMENTAL
Intervention: Triglycerides
Number of subjects: 514791
Study 32981134 — intervention group
Group type: EXPERIMENTAL
Intervention: apoA-I
Number of subjects: 514791
Study 35338314 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 35338314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 0
Study 33844928 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 68
Study 36336323 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold air blower (CAB)
Number of subjects: 20
Study 36336323 — intervention group
Group type: COMPARATOR
Intervention: Standard fan (FAN)
Number of subjects: 20
Study 36336323 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 20
Study 33624798 — intervention group
Group type: EXPERIMENTAL
Intervention: VVZ-149 Injections (10-hour intravenous infusion)
Number of subjects: 60
Study 33624798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33247955 — intervention group
Group type: EXPERIMENTAL
Intervention: berotralstat 150 mg
Number of subjects: 19
Study 33247955 — intervention group
Group type: EXPERIMENTAL
Intervention: berotralstat 110 mg
Number of subjects: 19
Study 33247955 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study 34383100 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (20 μg/day)
Number of subjects: 35
Study 34383100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 32588153 — intervention group
Group type: EXPERIMENTAL
Intervention: Daikenchuto (DKT) 15 g per day during the perioperative period
Number of subjects: 32
Study 32588153 — intervention group
Group type: EXPERIMENTAL
Intervention: Daikenchuto (DKT)
Number of subjects: 32
Study 32588153 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 35877930 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual cessation group (n=29)
Number of subjects: 70
Study 35877930 — intervention group
Group type: COMPARATOR
Intervention: Abrupt cessation group (n=41)
Number of subjects: 70
Study 35877930 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 70
Study 32567870 — intervention group
Group type: EXPERIMENTAL
Intervention: anticlust software package
Number of subjects: 0
Study 34710314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 21
Study 34710314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 33933734 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 0
Study 33933734 — intervention group
Group type: COMPARATOR
Intervention: Zinc deficiency
Number of subjects: 0
Study 33757140 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Parent Participation Program (EPPP)
Number of subjects: 147
Study 33757140 — intervention group
Group type: COMPARATOR
Intervention: Conventional Care (CC)
Number of subjects: 147
Study 33934476 — intervention group
Group type: EXPERIMENTAL
Intervention: Food supplement and topical solution containing nanosilicon
Number of subjects: 30
Study 33934476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35631185 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital food label intervention (Nutri-Score displayed next to products)
Number of subjects: 135
Study 33092404 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline 200 mg/day
Number of subjects: 112
Study 32828845 — intervention group
Group type: EXPERIMENTAL
Intervention: PRF‐CS
Number of subjects: 10
Study 32828845 — intervention group
Group type: COMPARATOR
Intervention: PRF‐X
Number of subjects: 10
Study 35981135 — intervention group
Group type: EXPERIMENTAL
Intervention: BROAD light therapy (very brightly illuminated room for at least 6 hours per day for 4 weeks)
Number of subjects: 62
Study 35981135 — intervention group
Group type: COMPARATOR
Intervention: Standard 10,000 lux SAD light box (30 minutes in front of the light box for 4 weeks)
Number of subjects: 62
Study 34151817 — intervention group
Group type: EXPERIMENTAL
Intervention: DBS-f stimulation ('on')
Number of subjects: 42
Study 34151817 — intervention group
Group type: COMPARATOR
Intervention: Sham DBS-f ('off')
Number of subjects: 42
Study 34304969 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care and exercise (3-weekly 40 min sessions of unsupervised, moderate-intensity home rowing program over 3 months)
Number of subjects: 45
Study 34304969 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 45
Study 32147878 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical occlusal reduction (Group O)
Number of subjects: 50
Study 32147878 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical occlusal reduction with round shoulder preparation (Group OS)
Number of subjects: 50
Study 32147878 — intervention group
Group type: COMPARATOR
Intervention: No preparation of tooth (Control group)
Number of subjects: 50
Study 32147878 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical occlusal reduction with a central groove (Group OG)
Number of subjects: 50
Study 32147878 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical occlusal reduction with round shoulder preparation and central groove (Group OSG)
Number of subjects: 50
Study 36414518 — intervention group
Group type: EXPERIMENTAL
Intervention: local neck treatment (NT) + JPS/oculomotor exercises (JPS/OC)
Number of subjects: 152
Study 36414518 — intervention group
Group type: EXPERIMENTAL
Intervention: local neck treatment (NT) + balance exercises
Number of subjects: 152
Study 36414518 — intervention group
Group type: EXPERIMENTAL
Intervention: all treatments (NT + JPS/OC + balance exercises)
Number of subjects: 152
Study 36414518 — intervention group
Group type: COMPARATOR
Intervention: local neck treatment (NT)
Number of subjects: 152
Study 33533581 — intervention group
Group type: EXPERIMENTAL
Intervention: Reversing half-hitch alternating post (RHAP)
Number of subjects: 20
Study 33533581 — intervention group
Group type: COMPARATOR
Intervention: Square knot
Number of subjects: 20
Study 32552446 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples Mindfulness-Based Intervention (C-MBI)
Number of subjects: 77
Study 32552446 — intervention group
Group type: COMPARATOR
Intervention: Individual Mindfulness-Based Intervention (I-MBI)
Number of subjects: 77
Study 33798455 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone (267 mg three times per day in week 1, 534 mg three times per day in week 2, and 801 mg three times per day thereafter)
Number of subjects: 127
Study 33798455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 35314480 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 13
Study 35314480 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 13
Study 35314480 — intervention group
Group type: COMPARATOR
Intervention: Tolvaptan alone
Number of subjects: 13
Study 35314480 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (Tolvaptan + Hydrochlorothiazide)
Number of subjects: 13
Study 34246198 — intervention group
Group type: EXPERIMENTAL
Intervention: vNOTES
Number of subjects: 67
Study 34246198 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopy
Number of subjects: 67
Study 32541171 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K1 ointment applied twice a day for 8 weeks
Number of subjects: 30
Study 32541171 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment applied twice a day for 8 weeks
Number of subjects: 30
Study 36082248 — intervention group
Group type: EXPERIMENTAL
Intervention: Maraviroc 150 or 600 mg/day
Number of subjects: 150
Study 36082248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 32513299 — intervention group
Group type: EXPERIMENTAL
Intervention: Anluohuaxian Pill
Number of subjects: 750
Study 32513299 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment (basic therapeutic drugs for COVID-19)
Number of subjects: 750
Study 34479602 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person education
Number of subjects: 88
Study 34479602 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual education
Number of subjects: 88
Study 34479602 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 88
Study 34185066 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 75
Study 34185066 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 75
Study 34751506 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitality Acupunch exercise program (3 times a week, 40 min each session for 6 months)
Number of subjects: 114
Study 34751506 — intervention group
Group type: COMPARATOR
Intervention: Routine daily activities (Control group)
Number of subjects: 114
Study 34751506 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitality Acupunch exercise program
Number of subjects: 114
Study 32597619 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate supplementation (0.3 g/kg per day for 7 days)
Number of subjects: 18
Study 32597619 — intervention group
Group type: COMPARATOR
Intervention: Dextrosol (control group)
Number of subjects: 18
Study 35701054 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured care intervention in type 2 diabetes (part of the ERMIES trial)
Number of subjects: 44
Study 35701054 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Literacy Questionnaire (used in second round interviews)
Number of subjects: 44
Study 35701054 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise management
Number of subjects: 44
Study 35701054 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support and relationship to health professionals
Number of subjects: 44
Study 32704155 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Observation (AO)
Number of subjects: 45
Study 32704155 — intervention group
Group type: COMPARATOR
Intervention: Motor Imagery (MI)
Number of subjects: 45
Study 32704155 — intervention group
Group type: COMPARATOR
Intervention: Placebo Observation (PO)
Number of subjects: 45
Study 34369695 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment with filiform needles inserted perpendicularly, 3 mm in depth, with electric stimulation (2 Hz, 30 min, 3 times a week for 14 treatments)
Number of subjects: 62
Study 34369695 — intervention group
Group type: COMPARATOR
Intervention: Placebo needling method (needle not inserted through skin) with electric stimulation (2 Hz, 30 min, 3 times a week for 14 treatments)
Number of subjects: 62
Study 34369695 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment
Number of subjects: 62
Study 34519668 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health app use
Number of subjects: 500
Study 34519668 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived stress
Number of subjects: 500
Study 34519668 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived need to seek help
Number of subjects: 500
Study 34519668 — intervention group
Group type: EXPERIMENTAL
Intervention: Past use of professional mental health services
Number of subjects: 500
Study 34519668 — intervention group
Group type: EXPERIMENTAL
Intervention: Social influence
Number of subjects: 500
Study 34519668 — intervention group
Group type: EXPERIMENTAL
Intervention: Privacy concerns
Number of subjects: 500
Study 34519668 — intervention group
Group type: EXPERIMENTAL
Intervention: Stigma, age, and gender
Number of subjects: 500
Study 34015765 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone mineral density (BMD) at heel
Number of subjects: 1523
Study 34015765 — intervention group
Group type: EXPERIMENTAL
Intervention: Other BMD sites (forearm, femoral neck, lumbar spine, total body)
Number of subjects: 1523
Study 34015765 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis (RA)
Number of subjects: 1523
Study 35616251 — intervention group
Group type: EXPERIMENTAL
Intervention: SI‐TEAS Group
Number of subjects: 300
Study 35616251 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure Group
Number of subjects: 300
Study 35616251 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupressure Group
Number of subjects: 300
Study 33632286 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular point acupressure group
Number of subjects: 360
Study 33632286 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham auricular point acupressure group
Number of subjects: 360
Study 33632286 — intervention group
Group type: COMPARATOR
Intervention: Blank control group
Number of subjects: 360
Study 32699168 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg once per day
Number of subjects: 132
Study 32699168 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg once per day with CPAP
Number of subjects: 132
Study 32699168 — intervention group
Group type: COMPARATOR
Intervention: CPAP alone (conventional care)
Number of subjects: 132
Study 32699168 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 132
Study 35688793 — intervention group
Group type: EXPERIMENTAL
Intervention: Low resistance kinetics
Number of subjects: 373
Study 35688793 — intervention group
Group type: EXPERIMENTAL
Intervention: High resistance kinetics
Number of subjects: 373
Study 35688793 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitive kinetics
Number of subjects: 373
Study 35688793 — intervention group
Group type: EXPERIMENTAL
Intervention: Refractory kinetics
Number of subjects: 373
Study 35688793 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete response (CR) with refractory kinetics
Number of subjects: 373